Newsroom European Pharmacopoeia
182nd session of the European Pharmacopoeia Commission: handover to a new Chair, newly elected Presidium and launch of the all-digital 12th Edition
The European Pharmacopoeia Commission (EPC) held its 182nd session on 17 and 18 June 2025. A summary of its outcome is available in the infographic below. Highlights will be published shortly on our website and the full list of adopted texts will be made available on the European Pharmacopoeia...
Pharmeuropa 37.3 just released
All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 37.3 is 30 September 2025. Users and interested parties are welcome to comment on these drafts. It...
All-digital 12th Edition marks a new era for the European Pharmacopoeia
The European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe is proud to announce the launch of the 12th Edition of the European Pharmacopoeia (Ph. Eur.). This edition – much more than just another number – ushers in a new, all-digital era for the primary...
EDQM On Air – A win for animals – Phasing out the rabbit pyrogen test
EDQM On Air, the podcast on public health brought to you by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe, has just released a new episode! The EDQM is committed to improving animal welfare in the context of scientific experiments and testing....
Renew your European Pharmacopoeia access
The launch of the new European Pharmacopoeia (Ph. Eur.) online platform marks the beginning of a new era for the Ph. Eur. Renew your licence today to consult the Ph. Eur. texts you need on a redesigned, user-friendly platform launched alongside the 12th Edition. In the new publication cycle, each...
Join us at CPhI China 2025
The EDQM will be participating at CPhI China, which will take place in Shanghai at the Shanghai New International Expo Centre (SNIEC) on 24-26 June 2025. Visit our stand E1C33 to learn more about the European Pharmacopoeia, our latest publications, what new products will be coming out in the...
Launch of the 12th Edition and new online-only platform
Step into the future with us as we launch the all-digital 12th edition of the European Pharmacopoeia (Ph. Eur.), soon available exclusively on a new online platform. This significant transition marks the end of the print version and the beginning of a new era for the European Pharmacopoeia, one...
Pharmacopoeial Discussion Group achievements
The Pharmacopoeial Discussion Group (PDG)1 held its interim videoconference on 6 March 2025. The discussions focused on the next phase of PDG’s global membership expansion initiative. As previously announced (“PDG announces global membership initiative”), the PDG launched this initiative in...
European Pharmacopoeia Commission elects its new Chair at 181st session
The European Pharmacopoeia Commission (EPC) elected its new Chair, Dr Eugenia Cogliandro, at its 181st Session held on 25 and 26 March 2025. She will take up her duties at the 182nd Session of the EPC on 17 June 2025 for a three-year term. Dr Cogliandro has been a member of the Italian delegation...
EPC adopts mycoplasmas general chapter and monographs, updated to incorporate latest analytical developments
During its 181st session in March 2025, the European Pharmacopoeia Commission (EPC) adopted general chapter 2.6.7. Mycoplasmas and 11 monographs referring to it, all of which have been revised to reflect the new European Pharmacopoeia (Ph. Eur.) approach to the detection of mycoplasma...
EPC adopts cutting-edge HTS chapter to enhance viral contaminant detection in biological products
The European Pharmacopoeia Commission (EPC) adopted a new general chapter, High-throughput sequencing for the detection of viral extraneous agents (2.6.41), during its 181st session in March 2025. The new chapter will be published in Issue 12.2 of the European Pharmacopoeia (Ph. Eur.) in October...
Revised general chapters for elemental analysis published in Pharmeuropa 37.2
Analytical procedures for elemental analysis are described in the following European Pharmacopoeia (Ph. Eur.) general chapters: 2.2.22. Atomic emission spectrometry; 2.2.23. Atomic absorption spectrometry; 2.2.57. Inductively coupled plasma-atomic emission spectrometry; 2.2.58. Inductively...
Public consultation on revised general chapter 5.1.6. Alternative methods for control of microbiological quality in Pharmeuropa 37.2
The European Pharmacopoeia (Ph. Eur.) is seeking stakeholder feedback on the revised general chapter 5.1.6. Alternative methods for control of microbiological quality, published in this quarter’s issue of Pharmeuropa 37.2 for comment. This chapter aims to facilitate the implementation of rapid...
EPC adopts groundbreaking chapter on cell-based preparations for human use
After several years of work by the Cell Therapy Products Working Party (CTP WP), the European Pharmacopoeia Commission (EPC) adopted the new general chapter Cell-based preparations for human use (5.32) during its 181st session in March 2025. The new chapter will be published in Issue 12.2 of the...
Outcome of the 181st session of the European Pharmacopoeia Commission, March 2025
The European Pharmacopoeia Commission (EPC) held its 181st session on 25 and 26 March 2025. A summary of its outcome is available in the infographic below. Highlights will be published shortly on our website and the full list of adopted texts will be made available on the European Pharmacopoeia...
Pharmeuropa 37.2 just released
All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 37.2 is 30 June 2025. Users and interested parties are welcome to comment on these drafts. It should be...
Modernising excipient monographs: revised identification techniques and new CRSs
In recent months, several revised excipient monographs and new reference standards have been added to the European Pharmacopoeia (Ph. Eur.). The aim of the changes is to support users by promoting modern IR identification techniques and replacing reference spectra with chemical reference...
EDQM On Air – The evolution of biologicals in the European Pharmacopoeia
EDQM On Air, the podcast on public health brought to you by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe, has just released a new episode! Biological medicinal products – or biologicals – are a class of pharmaceutical products derived or...
Online publication of study for establishment of Ph. Eur. Human anti-D immunoglobulin BRP batch 2
The EDQM’s Biological Standardisation Programme, a joint programme of the Council of Europe and the European Commission, has recently run a study to establish batch 2 of the European Pharmacopoeia (Ph. Eur.) Human anti-D immunoglobulin Biological Reference Preparation (BRP). The outcome of the...
Pharmacopoeial Discussion Group achievements
The Pharmacopoeial Discussion Group (PDG) held its annual meeting on 1 and 2 October 2024 in Strasbourg, France. The meeting marked the one-year anniversary of the PDG working with an expanded team of four members (see “PDG welcomes IPC as a member”). The PDG includes the European Pharmacopoeia...